Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
Nefropatía membranosa muy tardía secundaria a alemtuzumab en paciente con esclerosis múltiple
Área salud
Eating habits of patients with multiple sclerosis in three different countries: China, Spain and Cuba
Background Multiple sclerosis (MS) is a chronic immunological, inflammatory, demyelinating, and neurodegenerative disease. Nutrition has been considered a possible factor in the pathogenesis of MS for some years. There is currently no consensus on the […]
Área salud
Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab
Late-onset neutropaenia is defined as an absolute neutrophil count of 4 weeks after the last dose of rituximab, in the absence of other identifiable causes. Late-onset neutropaenia is a rare adverse reaction to rituximab (observed […]
Área salud
Sensitivity and specificity of visual evoked potentials for early diagnosis of demyelinating diseases
Introduction International criteria are used for the diagnosis of multiple sclerosis (MS) and Isolated Clinical Syndrome (ACS), and Neuromyelitis Optica (NMO). PEVs are not included in any of them. We intend to analyse the sensitivity […]